Tag: Anaphylactic Shock
Risks for Anaphylaxis Compared Among IV Iron Products
Rates of anaphylaxis low for IV iron products, but risk for anaphylaxis increased with iron dextran and ferumoxytol compared with iron sucrose
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Of 1,366 patients with immediate allergic reaction to first dose, six developed severe immediate allergic reaction after second dose
Unclear Labeling Tied to Sesame Food Allergy
Less than half of packaged food products tied to clinical reactions did not declare sesame on the label
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
$345 Million Settlement Proposed in EpiPen Lawsuits
Pfizer spokesperson denied any wrongdoing and said settlement was sought to avoid 'the distraction of continued litigation'
Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Guidance relates to risks for allergic reactions for mRNA (Moderna and Pfizer) and adenovirus vector (Johnson & Johnson) COVID-19 vaccines
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
